Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 12:29 pm Sale | 2023-12-31 | 13G | VectivBio Holding AG VECT | Eventide Asset Management, LLC | 0 0.000% | -3,405,644 (Position Closed) | Filing History |
| 2023-07-07 4:21 pm Purchase | 2023-06-29 | 13D | VectivBio Holding AG VECT | IRONWOOD PHARMACEUTICALS INC IRWD | 61,295,063 97.600% | 61,295,063 (New Position) | Filing History |
| 2023-06-05 4:12 pm Purchase | 2023-05-25 | 13G | VectivBio Holding AG VECT | Beryl Capital Management LLC | 4,462,538 7.100% | 4,462,538 (New Position) | Filing History |
| 2023-05-26 4:51 pm Sale | 2023-05-25 | 13G | VectivBio Holding AG VECT | Novo Holdings A/S | 0 0.000% | -3,339,484 (Position Closed) | Filing History |
| 2023-05-24 4:52 pm Sale | 2023-05-21 | 13D | VectivBio Holding AG VECT | ORBIMED ADVISORS LLC | 5,156,561 7.700% | -1,557,000 (-23.19%) | Filing History |
| 2023-02-14 5:12 pm Purchase | 2022-12-31 | 13G | VectivBio Holding AG VECT | ORBIMED ADVISORS LLC | 6,713,561 10.700% | 1,810,057 (+36.91%) | Filing History |
| 2023-02-14 3:03 pm Sale | 2022-12-31 | 13G | VectivBio Holding AG VECT | Cormorant Asset Management LP | 2,536,617 4.040% | -303,772 (-10.69%) | Filing History |
| 2023-02-14 2:06 pm Purchase | 2022-12-31 | 13G | VectivBio Holding AG VECT | Eventide Asset Management, LLC | 3,405,644 5.400% | 1,066,600 (+45.60%) | Filing History |
| 2023-02-14 08:26 am Purchase | 2022-12-31 | 13G | VectivBio Holding AG VECT | Citadel Advisors LLC | 3,967,835 6.300% | 1,247,019 (+45.83%) | Filing History |
| 2023-02-13 12:08 pm Purchase | 2022-12-31 | 13G | VectivBio Holding AG VECT | CHI Advisors LLC | 5,492,893 8.760% | 2,817,485 (+105.31%) | Filing History |
| 2023-02-02 1:24 pm Sale | 2022-12-31 | 13G | VectivBio Holding AG VECT | Novo Holdings A/S | 3,339,484 5.300% | -182,535 (-5.18%) | Filing History |
| 2022-12-13 4:00 pm Purchase | 2022-12-09 | 13D | VectivBio Holding AG VECT | Forbion Growth Opportunities Fund II Cooperatief U.A. | 5,129,270 8.200% | 1,651,010 (+47.47%) | Filing History |
| 2022-10-20 11:16 am Unchanged | 2022-10-17 | 13D | VectivBio Holding AG VECT | Bpifrance Participations S.A. | 2,806,217 4.500% | 0 (Unchanged) | Filing History |
| 2022-07-07 4:00 pm Purchase | 2022-06-27 | 13D | VectivBio Holding AG VECT | Forbion Growth Opportunities Fund II Cooperatief U.A. | 3,478,260 7.700% | 3,478,260 (New Position) | Filing History |
| 2022-06-28 4:07 pm Unchanged | 2022-06-17 | 13D | VectivBio Holding AG VECT | Bpifrance Participations S.A. | 2,806,217 6.200% | 0 (Unchanged) | Filing History |
| 2022-06-17 4:30 pm Purchase | 2021-12-31 | 13G | VectivBio Holding AG VECT | Cormorant Asset Management LP | 2,840,389 6.160% | 2,840,389 (New Position) | Filing History |
| 2022-02-14 11:37 am Purchase | 2021-12-31 | 13G | VectivBio Holding AG VECT | Eventide Asset Management, LLC | 2,339,044 6.700% | 2,339,044 (New Position) | Filing History |
| 2022-02-14 06:19 am Purchase | 2021-12-31 | 13G | VectivBio Holding AG VECT | Citadel Advisors LLC | 2,720,816 7.700% | 23,465 (+0.87%) | Filing History |
| 2022-02-11 4:51 pm Purchase | 2021-12-31 | 13G | VectivBio Holding AG VECT | ORBIMED ADVISORS LLC | 4,903,504 14.000% | 73,500 (+1.52%) | Filing History |
| 2022-02-11 12:59 pm Purchase | 2021-12-31 | 13G | VectivBio Holding AG VECT | CHI Advisors LLC | 2,675,408 7.610% | 2,675,408 (New Position) | Filing History |